Frankfurt Rhine-Main Metropolitan Area
Passionate about transforming pharmaceutical operations through innovation and precision. With over 15 years of leadership experience in global pharma giants, I specialize in Contract Development and Manufacturing (CDMO), sterile injectables, and active pharmaceutical ingredients (APIs). I currently lead a high-impact business with triple-digit million-euro revenue, delivering operational excellence and sustainable growth. My academic foundation includes a PhD in Genetics from the University of Cambridge and postdoctoral research at Harvard University—fueling a data-driven, science-first approach to strategic decision-making.
- Managing two API manufacturing sites in Austria and Italy (>350 FTEs) for global supply with full end-to-end operational and business responsibility. - Heading the global CDMO operations for sterile drug products filled in syringes, vials, ampoules, IV-bags, and bottles across more than 10 production facilities mainly in Europe and the USA, managing an annual budget in the triple-digit millions of Euros. - Overseeing the global API B2B business incl. Lactulose, Anti-Infectives, Peptides, and Oncology APIs, with an annual budget in the triple-digit million Euro range. - Member of the global TechOps leadership team overseeing 20+ global DP & DS manufacturing sites.
- Heading the global CDMO business for fill & finish services for sterile pharmaceuticals with full P&L responsibility for an annual triple digit million Euro budget at more than ten manufacturing sites in Europe, USA and Asia utilizing syringes, vials, bottles, ampoules and iv-bags. - Negotiated the contractual framework for multiple high-impact CMO partnerships with a triple digit million Euro business volume respectively. - Leading an international team located in Germany, Austria, Norway, Sweden and USA in charge of project and key account management, business development, marketing and controlling and steering the manufacturing sites and cross-functional teams within a matrix organization. - Leading M&A and divestment projects for manufacturing sites for respective CDMO work streams.
- Business development for contract development and manufacturing services of complex parenterals for the region Europe, Middle East and Africa. - Focus on Evonik's technology for parenteral sustained-release formulations (microparticles, nanoparticles, implants), besides other complex parenterals, such as liposomes, RNA delivery, drug conjugates, etc.).
- Business development for contract manufacturing of sterile pharmaceuticals. - Project manager for pharmaceutical contract development projects (07/2011 – 11/2014). - Design & coordination of galenical development incl. QbD and scale-up processes. - Negotiations of CDAs, quotations, development and supply agreements with global customers. - Market research & marketing functions for contract manufacturing services.
- Coordinated the implementation for SAP/APO at 14 world-wide production sites for managing forecasts of external customers. - Involved in a think-tank for improving global supply chain related processes. - Steered the supply chain of various IV drugs in Norway during a global drug shortage.
- Optimized the production planning for the packaging lines of the plant in Graz. - Carried out a Lean Management project focusing on sample management, improving the quality inspections for incoming materials and optimizing the knowledge management. - Conducted market research of various IV drugs for their suitability for pre-filled syringes. - Contributed to the global launch of a narcotic IV drug, focusing on the supply chain.
- Developed an assay for detecting multiple gene expression profiles through RNA in situ hybridization in Gryllus bimaculatus. Published in Development 138(22):5015-26.